NPPA issued the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 1 mg + Metformin Hydrochloride IP 1000mg

Jun 27, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 21, 2024, issued a notification regarding the fixation of the Retail price of each film-coated tablet containing: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 1 mg + Metformin Hydrochloride IP 1000mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 9.36/- for the Composition of Each film-coated tablet containing: Metformin (1000mg) (as Extended release) + Glimepiride(1mg).

• It has fixed the rate at Rs. 12.05/- for the Composition of Each film-coated tablet containing: Metformin (1000mg) (as Extended release) + Dapagliflozin(10mg).

• It has fixed the rate at Rs. 12.21/- for the Composition of Each film-coated tablet containing: Dapagliflozin 10mg.

[Notification no. - 19(4071)/2024/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT